|
|
|
|
|
|
What you should know for the 2014-15 Flu Season
What sort of flu season are we having? The flu season varies from one season to another. As of late December, the CDC says all national key indicators are elevated and about half of the country is experiencing high flu activity. Flu activity is expected to continue into the coming weeks, with increases occurring especially in those states that have not yet had significant activity. Read more..
Breakthrough May Impact Flu Vaccination
An analysis of 10 years' worth of data on human influenza B viruses has shed new light on the pathogen which can cause the seasonal flu. Findings from this study could help make flu immunization programs more effective; be better targeting vaccines or by eventually eliminating one of the flu lineages completely. Read more..
Staying Positive with Chronic Illness
As a patient advocate and patient with common variable immunodeficiency (CVID), Abbie Cornett is frequently asked by patients who are having difficultly coping with their illness how she copes with hers and how she stays positive. This is a difficult question for her. She says being positive isn't something that just happens; it is something she has to work on. Read more...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FFF Adds Two Products to Portfolio
FFF Enterprises now carries Trumenba, manufactured by Pfizer. Trumenba is a Meningoccal Group B vaccine for adults and children 10 to 25 years of age. This is available in a 0.5 mL SDV, either in a 5 pack or a 10 pack.
FFF has also added Nabi-HB, manufactured by Biotest Pharmaceuticals. This Hyperimmune is indicated for the treatment of acute exposure to blood containing hepatitis B surface antigen (HBsAg), perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg positive persons and household exposure to persons with acute HBV infection. These are available in a 1mL SDV and a 5mL SDV.
To order these products, call Wow! Customer Care at 800-843-7477. |
|
|
|
|
|
|
|
|
Rates per gram are effective January 1, 2015 through March 31, 2015.
Product |
J Codes |
ASP +6%
(before sequester)
|
ASP +4.3%*
(after sequester)
|
Bivigam |
J1556 |
76.94 |
75.70 |
Carimune NF |
J1566 |
53.46 |
52.60 |
Flebogamma 5% & 10% DIF |
J1572 |
72.28 |
71.12 |
Gammagard Liquid |
J1569 |
78.31 |
77.05 |
Gammagard S/D |
J1566 |
53.46 |
52.60 |
Gammaked |
J1561 |
80.44 |
79.15 |
Gammaplex |
J1557 |
71.83 |
70.68 |
Gamunex-C |
J1561 |
80.44 |
79.15 |
Octagam |
J1568 |
77.74 |
76.49 |
Privigen |
J1459 |
73.31 |
72.13 |
*Reflects 2% sequestration reduction applied to 80% Medicare payment portion as required under the Budget Control Act of 2011.
|
|
|
|
|
|
|
|
|
From Merck
Merck announces the successful completion of the tender offer to all of the outstanding shares of common stock of Cubist Pharmaceuticals, Inc. more »
From Protein Sciences
Protein Sciences wins Frost & Sullivan New Product Innovation Award for Flublok influenza vaccine more »
From Cromos™ Pharma
Cromos™ Pharma launches risk-sharing partnerships program with Biotech and Pharma Companies
more »
|
|
|
|
|
|
|
|
|
Give Us Your Feedback
Your feedback is important! Please email us at [email protected] to let us know what you think, topics you'd like us to address, or questions you'd like answered. |
|
|
|
|
|
|
|
Receive our informative magazines and e-Newsletter |
|
|
|
|
|
|
|
|
|
|
|
Order these complimentary
support materials |
|
|
|
|
|
|
|
|
|
|